JACKIE ODEN: Open Payments
NPI 1427043397 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$243 in 10 payments from 4 companies in 2025. Trend: 2023 $610 · 2024 $328 · 2025 $243
Food & beverage: $243
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $190 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $20 |
| Organon LLC | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: Veozah, NEXPLANON, GEMTESA.
Industry payments across NE — which companies pay providers there.
